Румунія -
румунська -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
lambda libere & legate rid
sc tody laboratories int. srl -
Румунія -
румунська -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
setinin 50 mg
actavis group ptc ehf. - quetiapinum - compr. elib. prel. - 50mg - antipsihotice diazepine, oxazepine si tiazepine
Румунія -
румунська -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
setinin 200 mg
actavis group ptc ehf. - quetiapinum - compr. elib. prel. - 200mg - antipsihotice diazepine, oxazepine si tiazepine
Румунія -
румунська -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
setinin 300 mg
actavis group ptc ehf. - quetiapinum - compr. elib. prel. - 300mg - antipsihotice diazepine, oxazepine si tiazepine
Румунія -
румунська -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
setinin 400 mg
actavis group ptc ehf. - quetiapinum - compr. elib. prel. - 400mg - antipsihotice diazepine, oxazepine si tiazepine
Молдова -
румунська -
AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)
lavomax neo 125 mg comprimate filmate
nijfarm sa - tiloronum - comprimate filmate - 125 mg
Європейський Союз -
румунська -
EMA (European Medicines Agency)
victrelis
merck sharp dohme ltd - boceprevir - hepatita c, cronică - antivirale pentru uz sistemic - victrelis este indicat pentru tratamentul hepatitei c cronice (chc) genotip-1 infecţie, în asociere cu interferon alfa şi ribavirină, la pacienţii adulţi cu boli hepatice compensate care sunt netratat anterior sau care au eşuat anterioare terapie.
Європейський Союз -
румунська -
EMA (European Medicines Agency)
evusheld
astrazeneca ab - tixagevimab, cilgavimab - covid-19 virus infection - prevention of covid-19.
Європейський Союз -
румунська -
EMA (European Medicines Agency)
tremfya
janssen-cilag international nv - guselkumab - psoriazis - imunosupresoare - plaque psoriasis tremfya is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritis tremfya, alone or in combination with methotrexate (mtx), is indicated for the treatment of active psoriatic arthritis in adult patients who have had an inadequate response or who have been intolerant to a prior disease-modifying antirheumatic drug (dmard) therapy (see section 5.